Jose Canseco and Human Genetic Engineering
By Osagie Obasogie,
Cincinnati Enquirer
| 10. 21. 2005
Will He Be Right Again?
Recently, Jose Canseco and I were guests on a talk show to discuss gene doping, the genetic equivalent to anabolic steroids - a way to "juice up" to gain a competitive edge. It is possible that in the next few years athletes will be able to enhance their performance by altering their genetic make-ups. Canseco argued that gene doping "is definitely the next big step in evolution." Genetic enhancement, he said, "goes way beyond sports. Imagine an army of a million individuals who can out-think, out-use the environment in the sense of less food, more reaction time, better vision, better physical reaction . . . (T)he human race . . . is going to evolve and no one's gonna stop it."
It's easy to dismiss this as the ramblings of a B-list star struggling to keep himself in the limelight. Indeed, when Canseco released his now infamous "Juiced: Wild Times, Rampant 'Roids, Smash Hits, and How Baseball Got Big," this was most people's response. Yet we have been forced to swallow the bitter truthfulness of Canseco's pill. In the few...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...